How can you help our commercial GMP drug substance launch to market?

Move forwards to commercialization faster with Abzena.

High-quality commercial-scale GMP manufacturing solutions for reliable, predictable performance.

Speed-to-market is critical. However, it should never come at the expense of quality. Abzena have the know-how to accelerate and move your drug candidate forwards, getting you from proof-of-concept (POC) to commercialization, faster. Our network of integrated state-of-the-art facilities can meet all your biologics manufacturing needs. We ensure that technology transfer and potential scale up from your facility to ours will meet all product quality requirements.

Developing an efficient, scalable, validated, and cost-effective manufacturing process in the late development phase is essential for success in today’s competitive biologics and bioconjugates market.

Whether you need assistance developing a new process, are improving existing processes, or are preparing to manufacture your product, you will benefit from our in-depth expertise. Through a comprehensive technology transfer program, we deliver a successful scale-up model to ensure a robust and consistent manufacturing process from clinical through commercial scale.

We collaborate with your team to de-risk the pathway to commercialization, ensure manufacturability, and deliver a quality biologic medicine to the patient.

Commercial Launch Enabling Activities

Designed to move medicine forward to commercial launch, Abzena are focused on two key enabling activities for those companies looking to bring biologics and bioconjugates to the market.

Our focus is on:

  • Scalable Manufacturing Campaigns: With two manufacturing trains, we can simultaneously produce material at different scales—supporting multiple clinical programs or enabling a commercial campaign in parallel with earlier-stage development batches.
  • Regulatory & Analytical Support: Abzena’s analytical and bioassay teams are integrated into every manufacturing campaign, ensuring real-time data on critical quality attributes (CQAs). This holistic support helps sponsors navigate IND/BLA submissions and maintain compliance throughout commercialization.

De-risking the pathway to commercialization

Abzena have the know-how and resources to meet your commercial needs. We collaborate with your team to de-risk the pathway to commercialization.

Through our technology transfer program and scale up model we can ensure a robust and consistent clinical to commercial manufacturing process. We ensure manufacturability, and will deliver a quality medicine to the patient.

Together, we can keep moving medicine forward.

The leading biologics CDMO + CRO that accelerates drug development, moving medicine forward for patients in need.